Sort   by:  
 Page size 
MetabolomicsLipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic and type 2 diabetic individuals

The relationship between dyslipidemia and type 2 diabetes mellitus (T2D) has been extensively reported, but the global lipid profiles, especially in the East Asia population, associated with the development of T2D remain to be characterized. Liquid chromatography coupled to tandem mass spectromet...

2017-04-26 | MTBLS352 | MetaboLights
MetabolomicsDeciphering the metabolic perturbation in hepatic alveolar echinococcosis: a 1H NMR-based metabolomics study

BACKGROUND: Hepatic alveolar echinococcosis (HAE) is caused by the growth of Echinococcus multilocularis larvae in the liver. It is a chronic and potentially lethal parasitic disease. Early stage diagnosis for this disease is currently not available due to its long asymptomatic ...

2021-08-03 | MTBLS981 | MetaboLights
UnknownIdentification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors.
Not available
S-EPMC2193410 | biostudies-literature
UnknownInsight into the formation of trumpet and needle-type leaf in Ginkgo biloba L. mutant.
Not available
S-EPMC9780455 | biostudies-literature
UnknownAssociations between overactive bladder and sleep patterns: a cross-sectional study based on 2007–2014 NHANES
Not available
S-EPMC10642019 | biostudies-literature
UnknownAnalysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.
Not available
S-EPMC8943947 | biostudies-literature
UnknownBiomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis.
Not available
S-EPMC8895626 | biostudies-literature
UnknownAlpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression
Not available
S-EPMC9461185 | biostudies-literature
MetabolomicsAltered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity

Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recurrent symptoms of abdominal pain and irregular defecation. Changed gut microbiota has been proposed to mediate IBS; however, contradictory results exist, and IBS-specific microbi...

2021-12-01 | MTBLS2774 | MetaboLights
UnknownA Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.
Not available
S-EPMC6732004 | biostudies-literature
Sort   by:  
 Page size